19,37,38 Through recognition of vitronectin receptor (αvβ3), the nanorods could specifically target the angiogenic endothelial cells in tumor region, and subsequently, selectively bind to the tumor cells via recognition of the folate receptor (FR). This evidence concerns the gene ITGAV and neoplasm.